RB

Rashmeen Bano

Director Director DIN 09541816
DIN 09541816 First appointment Mar 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2022
Shareholding value Locked Premium profile

About Rashmeen Bano

Data last updated:

Rashmeen Bano has 4 years in corporate governance. Formerly with 1 company, such as Zevitas Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09541816
Primary Designation Director
First Appointment 21 Mar 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Zevitas Pharma Private Limited U85300MH2022PTC378722
Director21 Mar 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zevitas Pharma Private Limited
Premium access

Shareholding and investment profile for Rashmeen Bano

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rashmeen Bano

Rashmeen Bano has 4 years in corporate governance. Formerly with 1 company, such as Zevitas Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Rashmeen Bano is associated with 0 companies as a director.

Rashmeen Bano has expertise in General Business.

Rashmeen Bano has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available